n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Neuralgia in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
Neuralgia: Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Staunton, CA | 1 |
| Barrett-Jolley, R | 1 |
| Djouhri, L | 1 |
| Thippeswamy, T | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Neuralgia
| Article | Year |
|---|---|
Inducible nitric oxide synthase inhibition by 1400W limits pain hypersensitivity in a neuropathic pain rat model.
Topics: Amidines; Animals; Benzylamines; Cytokines; Disease Models, Animal; Male; Neuralgia; Nitric Oxide; N | 2018 |